BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Neureiter D, Jäger T, Ocker M, Kiesslich T. Epigenetics and pancreatic cancer: Pathophysiology and novel treatment aspects. World J Gastroenterol 2014; 20(24): 7830-7848 [PMID: 24976721 DOI: 10.3748/wjg.v20.i24.7830]
URL: https://www.wjgnet.com/1007-9327/full/v20/i24/7830.htm
Number Citing Articles
1
Qiangsheng Hu, Yi Qin, Shunrong Ji, Wenyan Xu, Wensheng Liu, Qiqing Sun, Zheng Zhang, Mengqi Liu, Quanxing Ni, Xianjun Yu, Xiaowu Xu. UHRF1 promotes aerobic glycolysis and proliferation via suppression of SIRT4 in pancreatic cancerCancer Letters 2019; 452: 226 doi: 10.1016/j.canlet.2019.03.024
2
Elisabeth Hessmann, Steven A Johnsen, Jens T Siveke, Volker Ellenrieder. Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?Gut 2017; 66(1): 168 doi: 10.1136/gutjnl-2016-312539
3
Xiaoli Yin, Lingming Kong, Peng Liu. Identification of prognosis-related molecular subgroups based on DNA methylation in pancreatic cancerClinical Epigenetics 2021; 13(1) doi: 10.1186/s13148-021-01090-w
4
Michael Olivier, Reto Asmis, Gregory A. Hawkins, Timothy D. Howard, Laura A. Cox. The Need for Multi-Omics Biomarker Signatures in Precision MedicineInternational Journal of Molecular Sciences 2019; 20(19): 4781 doi: 10.3390/ijms20194781
5
Raúl Ortíz, Francisco Quiñonero, Beatriz García-Pinel, Marco Fuel, Cristina Mesas, Laura Cabeza, Consolación Melguizo, Jose Prados. Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent ProgressCancers 2021; 13(9): 2058 doi: 10.3390/cancers13092058
6
Dietrich A. Ruess, Kivanc Görgülü, Sonja M. Wörmann, Hana Algül. Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging ConceptsDrugs & Aging 2017; 34(5): 331 doi: 10.1007/s40266-017-0453-y
7
Ainhoa Mielgo, Michael C. Schmid. Liver Tropism in Cancer: The Hepatic Metastatic NicheCold Spring Harbor Perspectives in Medicine 2020; 10(3): a037259 doi: 10.1101/cshperspect.a037259
8
Myrna Hurtado, Umesh T. Sankpal, Amalendu Ranjan, Rajasekhar Maram, Jamboor K. Vishwanatha, Ganji Purnachandra Nagaraju, Bassel F. El-Rayes, Riyaz Basha. Investigational agents to enhance the efficacy of chemotherapy or radiation in pancreatic cancerCritical Reviews in Oncology/Hematology 2018; 126: 201 doi: 10.1016/j.critrevonc.2018.03.016
9
Sona Ciernikova, Julie Earl, María Laura García Bermejo, Viola Stevurkova, Alfredo Carrato, Bozena Smolkova. Epigenetic Landscape in Pancreatic Ductal Adenocarcinoma: On the Way to Overcoming Drug Resistance?International Journal of Molecular Sciences 2020; 21(11): 4091 doi: 10.3390/ijms21114091
10
Feda H. Hamdan, Steven A. Johnsen. Epigenetic Targeting of Aberrant Transcriptional Modulation in Pancreatic CancerEpigenomes 2018; 2(2): 8 doi: 10.3390/epigenomes2020008
11
P. A. Ávila-López, G. Guerrero, H. N. Nuñez-Martínez, C. A. Peralta-Alvarez, G. Hernández-Montes, L. G. Álvarez-Hilario, R. Herrera-Goepfert, J. Albores-Saavedra, N. Villegas-Sepúlveda, L. Cedillo-Barrón, A. E. Montes-Gómez, M. Vargas, M. Schnoor, F. Recillas-Targa, R. Hernández-Rivas. H2A.Z overexpression suppresses senescence and chemosensitivity in pancreatic ductal adenocarcinomaOncogene 2021; 40(11): 2065 doi: 10.1038/s41388-021-01664-1
12
Brittany Silverman, Jiaqi Shi. Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical ImplicationsInternational Journal of Molecular Sciences 2016; 17(12): 2138 doi: 10.3390/ijms17122138
13
Uroš Gašić, Ivanka Ćirić, Tomislav Pejčić, Dejan Radenković, Vladimir Djordjević, Siniša Radulović, Živoslav Tešić. Polyphenols as Possible Agents for Pancreatic DiseasesAntioxidants 2020; 9(6): 547 doi: 10.3390/antiox9060547
14
Yishuo Wang, Zhongyong Liu, Qinrong Liu, Yongguang Han, Yuncai Zang, Huichao Zhang, Xuzhao Du, Tao Qin, Yuquan Wu. <p>Honokiol Suppressed Pancreatic Cancer Progression via miR-101/Mcl-1 Axis</p>Cancer Management and Research 2020; : 5243 doi: 10.2147/CMAR.S237323
15
Afsaneh Barzi, Rebecca Miksad, Andy Surinach, Frank A. Corvino, Siqi Wang, Aracelis Z. Torres, Khalid Mamlouk, Sonia Pulgar, Adriana Valderrama, Tanios Bekaii-Saab, Daniel Ahn. Real-World Dosing Patterns and Outcomes of Patients With Metastatic Pancreatic Cancer Treated With a Liposomal Irinotecan Regimen in the United StatesPancreas 2020; 49(2): 193 doi: 10.1097/MPA.0000000000001479
16
Ti-Dong Shan, Ji-Hao Xu, Tao Yu, Jie-Yao Li, Lin-Na Zhao, Hui Ouyang, Su Luo, Xi-Ji Lu, Can-Ze Huang, Qiu-Shen Lan, Wa Zhong, Qi-Kui Chen. Knockdown of linc-POU3F3 suppresses the proliferation, apoptosis, and migration resistance of colorectal cancerOncotarget 2016; 7(1): 961 doi: 10.18632/oncotarget.5830
17
Bo Tang, Yang Li, Guangying Qi, Shengguang Yuan, Zhenran Wang, Shuiping Yu, Bo Li, Songqing He. Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic CancerScientific Reports 2015; 5(1) doi: 10.1038/srep13563
18
E. A. Bykova, N. A. Falaleeva, L. Yu. Grivtsova. PANCREATIC CANCER, CURRENT THERAPEUTIC APPROACHES AND POSSIBLE PROSPECTSRussian Journal of Biotherapy 2020; 19(4): 18 doi: 10.17650/1726-9784-2020-19-4-18-28
19
Brooke D. Paradise, Whitney Barham, Martín E. Fernandez-Zapico. Targeting Epigenetic Aberrations in Pancreatic Cancer, a New Path to Improve Patient Outcomes?Cancers 2018; 10(5): 128 doi: 10.3390/cancers10050128
20
Masoumeh Kiani-Zadeh, Mohammad Reza Rezvany, Soodeh Namjoo, Mahmood Barati, Mohammad Hossein Mohammadi, Bahare Ghasemi, Tahere Tabatabaei, Ardeshir Ghavamzadeh, Farhad Zaker, Ladan Teimoori-Toolabi. Studying the potential of upregulated PTGS2 and VEGF-C besides hyper-methylation of PTGS2 promoter as biomarkers of Acute myeloid leukemiaMolecular Biology Reports 2022; 49(8): 7849 doi: 10.1007/s11033-022-07615-7
21
Mansunderbir Singh, Priyanka Anvekar, Bhavana Baraskar, Namratha Pallipamu, Srikanth Gadam, Akhila Sai Sree Cherukuri, Devanshi N. Damani, Kanchan Kulkarni, Shivaram P. Arunachalam. Prospective of Pancreatic Cancer Diagnosis Using Cardiac SensingJournal of Imaging 2023; 9(8): 149 doi: 10.3390/jimaging9080149
22
Kelly Foley, Victoria Kim, Elizabeth Jaffee, Lei Zheng. Current progress in immunotherapy for pancreatic cancerCancer Letters 2016; 381(1): 244 doi: 10.1016/j.canlet.2015.12.020
23
Verónica del Carmen Martínez‐Jiménez, Alejandro Méndez‐Mancilla, Diana Patricia Portales‐Pérez. miRNAs in nutrition, obesity, and cancer: The biology of miRNAs in metabolic disorders and its relationship with cancer developmentMolecular Nutrition & Food Research 2018; 62(1) doi: 10.1002/mnfr.201600994
24
Junya Peng, Bao-Fa Sun, Chuan-Yuan Chen, Jia-Yi Zhou, Yu-Sheng Chen, Hao Chen, Lulu Liu, Dan Huang, Jialin Jiang, Guan-Shen Cui, Ying Yang, Wenze Wang, Dan Guo, Menghua Dai, Junchao Guo, Taiping Zhang, Quan Liao, Yi Liu, Yong-Liang Zhao, Da-Li Han, Yupei Zhao, Yun-Gui Yang, Wenming Wu. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinomaCell Research 2019; 29(9): 725 doi: 10.1038/s41422-019-0195-y
25
Sara Asgharzadeh, Farzaneh Tafvizi, Vahid Chaleshi, Shahrokh Iravani. Lack of association between LincRNA-Pou3f gene expression and clinicopathological features in gastric cancer tissueGene Reports 2020; 20: 100700 doi: 10.1016/j.genrep.2020.100700
26
Anna-Laura Kretz, Silvia Von Karstedt, Andreas Hillenbrand, Doris Henne-Bruns, Uwe Knippschild, Anna Trauzold, Johannes Lemke. Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer TherapyCancers 2018; 10(3): 77 doi: 10.3390/cancers10030077
27
Hua Liu, Xuan-Fu Xu, Yan Zhao, Mao-Chun Tang, Ying-Qun Zhou, Jie Lu, Feng-Hou Gao. MicroRNA-191 promotes pancreatic cancer progression by targeting USP10Tumor Biology 2014; 35(12): 12157 doi: 10.1007/s13277-014-2521-9
28
Caiting Yang, Peike Peng, Lili Li, Miaomiao Shao, Junjie Zhao, Lan Wang, Fangfang Duan, Shushu Song, Hao Wu, Jie Zhang, Ran Zhao, Dongwei Jia, Mingming Zhang, Weicheng Wu, Can Li, Yefei Rong, Lei Zhang, Yuanyuan Ruan, Jianxin Gu. High expression of GFAT1 predicts poor prognosis in patients with pancreatic cancerScientific Reports 2016; 6(1) doi: 10.1038/srep39044
29
Max M. Träger, Sameer A. Dhayat. Epigenetics of epithelial‐to‐mesenchymal transition in pancreatic carcinomaInternational Journal of Cancer 2017; 141(1): 24 doi: 10.1002/ijc.30626
30
Monika Bauden, Dorian Pamart, Daniel Ansari, Marielle Herzog, Mark Eccleston, Jake Micallef, Bodil Andersson, Roland Andersson. Circulating nucleosomes as epigenetic biomarkers in pancreatic cancerClinical Epigenetics 2015; 7(1) doi: 10.1186/s13148-015-0139-4
31
Kathy A. Gelato, David Adler, Matthias Ocker, Bernard Haendler. Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAsExpert Opinion on Therapeutic Targets 2016; 20(7): 783 doi: 10.1517/14728222.2016.1134490
32
Zhao-Chun Chi. Research status and prgoress of nonalcoholic fatty pancreatic diseaseWorld Chinese Journal of Digestology 2020; 28(19): 933 doi: 10.11569/wcjd.v28.i19.933
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
33
Jae-Seok Roe, Chang-Il Hwang, Tim D.D. Somerville, Joseph P. Milazzo, Eun Jung Lee, Brandon Da Silva, Laura Maiorino, Hervé Tiriac, C. Megan Young, Koji Miyabayashi, Dea Filippini, Brianna Creighton, Richard A. Burkhart, Jonathan M. Buscaglia, Edward J. Kim, Jean L. Grem, Audrey J. Lazenby, James A. Grunkemeyer, Michael A. Hollingsworth, Paul M. Grandgenett, Mikala Egeblad, Youngkyu Park, David A. Tuveson, Christopher R. Vakoc. Enhancer Reprogramming Promotes Pancreatic Cancer MetastasisCell 2017; 170(5): 875 doi: 10.1016/j.cell.2017.07.007
34
Sung Hwan Cho, Mihyang Ha, Yong Hoon Cho, Je Ho Ryu, Kwangho Yang, Kang Ho Lee, Myoung-Eun Han, Sae-Ock Oh, Yun Hak Kim. ALKBH5gene is a novel biomarker that predicts the prognosis of pancreatic cancer: A retrospective multicohort studyAnnals of Hepato-Biliary-Pancreatic Surgery 2018; 22(4): 305 doi: 10.14701/ahbps.2018.22.4.305
35
Ti‐Dong Shan, Zi‐Bin Tian, Qian Li, Yue‐ Ping Jiang, Fu‐Guo Liu, Xue‐Guo Sun, Yue Han, Li‐Juan Sun, Li Chen. Long intergenic noncoding RNA 00908 promotes proliferation and inhibits apoptosis of colorectal cancer cells by regulating KLF5 expressionJournal of Cellular Physiology 2021; 236(2): 889 doi: 10.1002/jcp.29899
36
Huiming Chen, Yan Kong, Qing Yao, Xing Zhang, Yunong Fu, Jia Li, Chang Liu, Zheng Wang. Three hypomethylated genes were associated with poor overall survival in pancreatic cancer patientsAging 2019; 11(3): 885 doi: 10.18632/aging.101785
37
Monika Bauden, Helena Tassidis, Daniel Ansari. In vitro cytotoxicity evaluation of HDAC inhibitor Apicidin in pancreatic carcinoma cells subsequent time and dose dependent treatmentToxicology Letters 2015; 236(1): 8 doi: 10.1016/j.toxlet.2015.03.017
38
Rituraj Chakraborty, Anupam Dutta, Bhargab Jyoti Baruah, Rajni Kumari, Priyanku Sarma, Ankita Sharma, Krishangi Goswami, Haritha Myakala, Akalesh Kumar Verma. Pancreatic Cancer: A Review on Pathophysiology, Naturopathy, Clinical Treatment and OutcomesCurrent Cancer Therapy Reviews 2024; 20(3): 263 doi: 10.2174/1573394719666230830125213
39
Fengjin Zhao, Tianxin Lin, Wang He, Jinli Han, Dingjun Zhu, Kaishun Hu, Weicong Li, Zaosong Zheng, Jian Huang, Wenlian Xie. Knockdown of a novel lincRNA AATBC suppresses proliferation and induces apoptosis in bladder cancerOncotarget 2015; 6(2): 1064 doi: 10.18632/oncotarget.2833
40
Shan Jiang, Johan Bourghardt Fagman, Yunyun Ma, Jian Liu, Caroline Vihav, Cecilia Engstrom, Beidong Liu, Changyan Chen. A comprehensive review of pancreatic cancer and its therapeutic challengesAging 2022; 14(18): 7635 doi: 10.18632/aging.204310
41
Roseane Guimarães Ferreira, Luis Eduardo Mosquera Narvaez, Kaio Murilo Monteiro Espíndola, Amanda Caroline R. S. Rosario, Wenddy Graziela N. Lima, Marta Chagas Monteiro. Can Nimesulide Nanoparticles Be a Therapeutic Strategy for the Inhibition of the KRAS/PTEN Signaling Pathway in Pancreatic Cancer?Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.594917
42
Shin-Heng Chiou, Madeleine Dorsch, Eva Kusch, Santiago Naranjo, Margaret M. Kozak, Albert C. Koong, Monte M. Winslow, Barbara M. Grüner. Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistanceScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-32159-x
43
Peng Xia, Pan Liu, Qiang Fu, Chuanjiang Liu, Qiankun Luo, Xu Zhang, Liyou Cheng, Tao Qin, Hongwei Zhang. Long noncoding RNA EPIC1 interacts with YAP1 to regulate the cell cycle and promote the growth of pancreatic cancer cellsBiochemical and Biophysical Research Communications 2020; 522(4): 978 doi: 10.1016/j.bbrc.2019.11.167
44
Ting Zhang, Linglin Zhao, Shengyuan Zeng, Lu Bai, Junxia Chen, Zheng Zhang, Yalan Wang, Changzhu Duan. UHRF2 decreases H3K9ac expression by interacting with it through the PHD and SRA/YDG domain in HepG2 hepatocellular carcinoma cellsInternational Journal of Molecular Medicine 2017; 39(1): 126 doi: 10.3892/ijmm.2016.2805
45
Inês Faleiro, Vânia Palma Roberto, Secil Demirkol Canli, Nicolas A. Fraunhoffer, Juan Iovanna, Ali Osmay Gure, Wolfgang Link, Pedro Castelo-Branco. DNA Methylation of PI3K/AKT Pathway-Related Genes Predicts Outcome in Patients with Pancreatic Cancer: A Comprehensive Bioinformatics-Based StudyCancers 2021; 13(24): 6354 doi: 10.3390/cancers13246354
46
Pascal Syren, Roland Andersson, Monika Bauden, Daniel Ansari. Epigenetic alterations as biomarkers in pancreatic ductal adenocarcinomaScandinavian Journal of Gastroenterology 2017; 52(6-7): 668 doi: 10.1080/00365521.2017.1301989
47
Zhiming Zhao, Mengyang Li, Xianglong Tan, Dabin Xu, Rong Liu. Methylation Patterns Partition Pancreatic Cancer into Distinct Prognostic SubtypesFuture Oncology 2021; 17(16): 2027 doi: 10.2217/fon-2020-0804
48
Liu Yang, Yinan Zhang, Jun Bao, Ji-Feng Feng. Long non-coding RNA BCYRN1 exerts an oncogenic role in colorectal cancer by regulating the miR-204-3p/KRAS axisCancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01543-x
49
Andee Weisbeck, Rick Jansen. Nutrients and the Pancreas: An Epigenetic PerspectiveNutrients 2017; 9(3): 283 doi: 10.3390/nu9030283
50
Gang Ning, Yongqiang Li, Wenji Chen, Wenjuan Tang, Diwen Shou, Qingling Luo, Huiting Chen, Yongjian Zhou, Reem Saleh. CpG Island Methylator Phenotype Modulates the Immune Response of the Tumor Microenvironment and Influences the Prognosis of Pancreatic Cancer PatientsJournal of Oncology 2021; 2021: 1 doi: 10.1155/2021/2715694
51
Prakash Chaudhary, Diwakar Guragain, Jae-Hoon Chang, Jung-Ae Kim. TPH1 and 5-HT7 Receptor Overexpression Leading to Gemcitabine-Resistance Requires Non-Canonical Permissive Action of EZH2 in Pancreatic Ductal AdenocarcinomaCancers 2021; 13(21): 5305 doi: 10.3390/cancers13215305
52
T Yu, T-D Shan, J-Y Li, C-Z Huang, S-Y Wang, H Ouyang, X-J Lu, J-H Xu, W Zhong, Q-K Chen. Knockdown of linc-UFC1 suppresses proliferation and induces apoptosis of colorectal cancerCell Death & Disease 2016; 7(5): e2228 doi: 10.1038/cddis.2016.124
53
Juan Pablo Arnoletti, Xiang Zhu, Alvin J.O. Almodovar, Paula P. Veldhuis, Ryan Sause, Elizabeth Griffith, George Corpus, Jeffrey C.C. Chang, Na'im Fanaian, Sally A. Litherland. Portal Venous Blood Circulation Supports Immunosuppressive Environment and Pancreatic Cancer Circulating Tumor Cell ActivationPancreas 2017; 46(1): 116 doi: 10.1097/MPA.0000000000000667
54
Marina Ayres Pereira, Iok In Christine Chio. Metastasis in Pancreatic Ductal Adenocarcinoma: Current Standing and MethodologiesGenes 2019; 11(1): 6 doi: 10.3390/genes11010006
55
Emily Chan, E. Gabriela Chiorean, Peter J. O’Dwyer, Nashat Y. Gabrail, Thierry Alcindor, Diane Potvin, Richard Chao, Herbert Hurwitz. Phase I/II study of mocetinostat in combination with gemcitabine for patients with advanced pancreatic cancer and other advanced solid tumorsCancer Chemotherapy and Pharmacology 2018; 81(2): 355 doi: 10.1007/s00280-017-3494-3
56
Marwa Elsayed, Maen Abdelrahim. The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel TherapiesBiomedicines 2021; 9(4): 389 doi: 10.3390/biomedicines9040389
57
Nitish Kumar Mishra, Siddesh Southekal, Chittibabu Guda. Survival Analysis of Multi-Omics Data Identifies Potential Prognostic Markers of Pancreatic Ductal AdenocarcinomaFrontiers in Genetics 2019; 10 doi: 10.3389/fgene.2019.00624
58
M.J. Lamberti, R.E. Vera, N.B. Rumie Vittar, G. Schneider. Chromatin Signaling and Diseases2016; : 169 doi: 10.1016/B978-0-12-802389-1.00009-5
59
Rahul R. Singh, Katie M. Reindl, Rick J. Jansen. Epigenomics of Pancreatic Cancer: A Critical Role for Epigenome-Wide StudiesEpigenomes 2019; 3(1): 5 doi: 10.3390/epigenomes3010005
60
Pinar Erkekoglu. Oncogenes and Carcinogenesis2019;  doi: 10.5772/intechopen.82459
61
Rong Tang, Yiyin Zhang, Chen Liang, Jin Xu, Qingcai Meng, Jie Hua, Jiang Liu, Bo Zhang, Xianjun Yu, Si Shi. The role of m6A-related genes in the prognosis and immune microenvironment of pancreatic adenocarcinomaPeerJ 2020; 8: e9602 doi: 10.7717/peerj.9602
62
Akash Bararia, Amlan Das, Sangeeta Mitra, Sudeep Banerjee, Aniruddha Chatterjee, Nilabja Sikdar. Deoxyribonucleic acid methylation driven aberrations in pancreatic cancer-related pathwaysWorld Journal of Gastrointestinal Oncology 2023; 15(9): 1505-1519 doi: 10.4251/wjgo.v15.i9.1505
63
Sanjay Kumar, Rajesh Singh, Manoj K. Mishra. Epigenetic Mechanisms in Cancer2018; : 117 doi: 10.1016/B978-0-12-809552-2.00005-X
64
Manoj Kumar Gupta, Ramakrishna Vadde. Immune Landscape of Pancreatic Cancer Development and Drug Resistance2024; : 173 doi: 10.1016/B978-0-443-23523-8.00004-3
65
Hironori Hayashi, Koji Amaya, Tomokazu Tokoro, Kosuke Mori, Shunsuke Takenaka, Yuya Sugimoto, Yuto Kitano, Toru Kurata, Shunsuke Kawai, Atsushi Hirose, Tomoya Tsukada, Masahide Kaji, Koichi Shimizu, Kiichi Maeda. Clinical features of patients with pancreatic ductal adenocarcinoma with a history of other primary malignancies: A retrospective analysisMolecular and Clinical Oncology 2021; 15(3) doi: 10.3892/mco.2021.2335
66
Claudia C. Preston, Randolph S. Faustino. Nuclear Envelope Regulation of Oncogenic Processes: Roles in Pancreatic CancerEpigenomes 2018; 2(3): 15 doi: 10.3390/epigenomes2030015
67
Zheng Lu, Zheng-Quan Lai, Albert W.N. Leung, Po Sing Leung, Zhao-Shen Li, Zhi-Xiu Lin. Exploring brusatol as a new anti-pancreatic cancer adjuvant: biological evaluation and mechanistic studiesOncotarget 2017; 8(49): 84974 doi: 10.18632/oncotarget.17761
68
David E. Amacher. A 2015 survey of established or potential epigenetic biomarkers for the accurate detection of human cancersBiomarkers 2016; 21(5): 387 doi: 10.3109/1354750X.2016.1153724
69
Fundamentals of Cancer Detection, Treatment, and Prevention2022; : 341 doi: 10.1002/9783527838561.ch15
70
Xiao Yu, Yun Wang, Xiaoyi Shi, Zhihui Wang, Peihao Wen, Yuting He, Wenzhi Guo. Dysfunctional epigenetic protein-coding gene-related signature is associated with the prognosis of pancreatic cancer based on histone modification and transcriptome analysisScientific Reports 2023; 13(1) doi: 10.1038/s41598-022-27316-2
71
Asaad Azarnezhad, Parvin Mehdipour. Cancer Genetics and Psychotherapy2017; : 79 doi: 10.1007/978-3-319-64550-6_5
72
Ting He, Fangli Zhou, Anping Su, Yujie Zhang, Zhichao Xing, Li Mi, Zhihui Li, Wenshuang Wu. Brusatol: A potential sensitizing agent for cancer therapy from Brucea javanicaBiomedicine & Pharmacotherapy 2023; 158: 114134 doi: 10.1016/j.biopha.2022.114134